NODAGA-RGD for imaging αvβ3 integrin expression

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 7, 2011, Pages 1303-1312

  Knetsch, Peter A ^a   Petrik, Milos ^a   Griessinger, Christoph M ^b   Rangger, Christine ^a   Fani, Melpomeni ^c   Kesenheimer, Christian ^b   Von Guggenberg, Elisabeth ^a   Pichler, Bernd J ^b   Virgolini, Irene ^a   Decristoforo, Clemens ^a   Haubner, Roland ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

v 3; 68Ga; Angiogenesis; Molecular imaging; NODAGA; RGD peptides

Indexed keywords

ARGININE; ASPARTIC ACID; GALLIUM 68; GLYCINE; PHOSPHATE BUFFERED SALINE; TRACER; VITRONECTIN RECEPTOR; 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID; 1,4,7-TRIAZACYCLONONANE-N,N',N''-TRIACETIC ACID; 68GA NODAGA RGD; 68GA-NODAGA-RGD; ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; COORDINATION COMPOUND; CYCLOPEPTIDE; DIAGNOSTIC AGENT; HETEROCYCLIC COMPOUND; OLIGOPEPTIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; IC 50; IN VITRO STUDY; IN VIVO CULTURE; INCUBATION TIME; ISOTOPE LABELING; MELANOMA; MOLECULAR IMAGING; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PH; POSITRON EMISSION TOMOGRAPHY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STABILITY; REACTION TIME; ROOM TEMPERATURE; SERUM; SOLID PHASE SYNTHESIS; TEMPERATURE; TUMOR CELL; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; METHODOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COORDINATION COMPLEXES; GENE EXPRESSION REGULATION; HETEROCYCLIC COMPOUNDS; HUMANS; INTEGRIN ALPHAVBETA3; ISOTOPE LABELING; MICE; OLIGOPEPTIDES; PEPTIDES, CYCLIC; POSITRON-EMISSION TOMOGRAPHY;

EID: 79958025504     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1778-0     Document Type: Article

References (22)

1. Z Szekanecz T Besenyei A Szentpétery AE Koch 2010 Angiogenesis and vasculogenesis in rheumatoid arthritis Curr Opin Rheumatol 22 299 306 20305562 10.1097/BOR.0b013e328337c95a 1:CAS:528:DC%2BC3cXjvFCltbc%3D
2. R Heidenreich M Röcken K Ghoreschi 2009 Angiogenesis drives psoriasis pathogenesis Int J Exp Pathol 90 232 248 19563608 10.1111/j.1365-2613. 2009.00669.x 1:CAS:528:DC%2BD1MXotV2ju7k%3D
3. HF Langer R Haubner BJ Pichler M Gawaz 2008 Radionuclide imaging: a molecular key to the atherosclerotic plaque J Am Coll Cardiol 52 1 12 18582628 10.1016/j.jacc.2008.03.036 1:CAS:528:DC%2BD1cXnvVGlt7o%3D (Pubitemid 351852936)
4. J Folkman 2007 Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6 273 286 17396134 10.1038/nrd2115 1:CAS:528: DC%2BD2sXjs1SisL4%3D (Pubitemid 46505878)
5. HM Sheldrake LH Patterson 2009 Function and antagonism of beta3 integrins in the development of cancer therapy Curr Cancer Drug Targets 9 519 540 19519320 10.2174/156800909788486713 1:CAS:528:DC%2BD1MXotlWrsro%3D
6. R Haubner C Decristoforo 2009 Radiolabelled RGD peptides and peptidomimetics for tumour targeting Front Biosci 14 872 886 19273105 10.2741/3283 1:CAS:528:DC%2BD1MXltFejt7Y%3D
7. E Ruoslahti MD Pierschbacher 1987 New perspectives in cell adhesion: RGD and integrins Science 238 491 497 2821619 10.1126/science.2821619 1:CAS:528:DyaL1cXntVKkuw%3D%3D (Pubitemid 17147032)
8. R Haubner HJ Wester U Reuning R Senekowitsch-Schmidtke B Diefenbach H Kessler, et al. 1999 Radiolabeled alpha(v)beta3 antagonists: a new class of tracers for tumor targeting J Nucl Med 40 1061 1071 10452325 1:CAS:528:DyaK1MXktVaqsLg%3D (Pubitemid 29269229)
9. R Haubner A Beer H Wang X Chen 2010 Positron emission tomography tracers for imaging angiogenesis Eur J Nucl Med Mol Imaging 37 Suppl 1 S86 S103 20559632 10.1007/s00259-010-1503-4
10. R Haubner B Kuhnast C Mang WA Weber H Kessler HJ Wester, et al. 2004 [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates Bioconjug Chem 15 61 69 14733584 10.1021/bc034170n 1:CAS:528:DC%2BD3sXpslWns7Y%3D (Pubitemid 38165981)
11. C Decristoforo I Hernandez Gonzalez J Carlsen M Rupprich M Huisman I Virgolini, et al. 2008 (68)Ga- and (111)In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression Eur J Nucl Med Mol Imaging 35 1507 1515 18369617 10.1007/s00259-008-0757-6
12. Y Sun CJ Anderson TS Pajeau DE Reichert RD Hancock RJ Motekaitis, et al. 1996 Indium(III) and gallium(III) complexes of bis(aminoethanethiol) ligands with different denticities: stabilities, molecular modeling, and in vivo behavior J Med Chem 39 458 470 8558514 10.1021/jm9505977 1:CAS:528:DyaK28XmvVyh (Pubitemid 26041458)
13. KP Eisenwiener MI Prata I Buschmann HW Zhang AC Santos S Wenger, et al. 2002 NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors Bioconjug Chem 13 530 541 12009943 10.1021/bc010074f 1:CAS:528:DC%2BD38XjtVaitr4%3D (Pubitemid 34535940)
14. R Haubner HJ Wester F Burkhart R Senekowitsch-Schmidtke W Weber SL Goodman, et al. 2001 Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics J Nucl Med 42 326 336 11216533 1:CAS:528:DC%2BD3MXhtlKmt7w%3D (Pubitemid 32150525)
15. C Decristoforo I Santos HJ Pietzsch JU Kuenstler A Duatti CJ Smith, et al. 2007 Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores Q J Nucl Med Mol Imaging 51 33 41 17372571 1:STN:280:DC%2BD2s7nsVWqsQ%3D%3D (Pubitemid 46824660)
16. A Kurtaran C Müller G Novacek K Kaserer M Mentes M Raderer, et al. 1997 Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbumin J Nucl Med 38 1912 1915 9430468 1:STN:280:DyaK1c%2FptVegsQ%3D%3D (Pubitemid 28030921)
17. RD Shannon 1976 Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides Acta Crystallogr A 32 751 767 10.1107/S0567739476001551
18. D Reichert J Lewis C Anderson 1999 Metal complexes as diagnostic tools Coord Chem Rev 184 3 66 10.1016/S0010-8545(98)00207-0 1:CAS:528: DyaK1MXivFyqs7c%3D
19. R Haubner HJ Wester WA Weber C Mang SI Ziegler SL Goodman, et al. 2001 Noninvasive imaging of αvβ3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography Cancer Res 61 1781 1785 11280722 1:CAS:528:DC%2BD3MXit1Ohtbk%3D (Pubitemid 32691983)
20. JM Jeong MK Hong YS Chang YS Lee YJ Kim GJ Cheon, et al. 2008 Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice J Nucl Med 49 830 836 18413379 10.2967/jnumed.107. 047423 1:CAS:528:DC%2BD1cXmvVSju7k%3D (Pubitemid 351717550)
21. ZB Li K Chen X Chen 2008 (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression Eur J Nucl Med Mol Imaging 35 1100 1108 18204838 10.1007/s00259-007-0692-y 1:CAS:528: DC%2BD1cXlvVClt70%3D
22. S Liu Z Liu K Chen Y Yan P Watzlowik HJ Wester, et al. 2010 (18)F-Labeled Galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression Mol Imaging Biol 12 530 538 19949981 10.1007/s11307-009-0284-2